The Latest Medical Devices Articles from Streetwise Reports


Medical Device Company's Improved Fundamentals Offer Multiple Expansion Potential

Research Report
  ()
ROTH Capital Partners LLC commented in a research report that it is maintaining its "Buy" rating and raising its FY/22 revenue estimates for Dynatronics Corp. to $41 million after the firm pre-announced Q4/21 revenue figures that exceeded prior estimates. read more >

Third Implantation of Device Firm's Total Artificial Heart That 'Could Save Many Patients Who May Die'

Research Report
  ()
An H.C. Wainwright & Co. report noted that Carmat's Aeson implant "could save many patients who may die, due to [a] shortage of donor hearts, while waiting for a heart transplant." read more >

Dermatological Device Company to Acquire Laser System Firm

Research Report
  ()
An H.C. Wainwright report noted that "this deal is an opportunity for STRATA Skin Sciences to substantially increase its long-term, recurring revenue base." read more >

Diagnostics Firm Readies for Pivotal FDA Study of Device That Detects Bacterial Lung Infections

  ()
Promising early results and a new line of equity support Avisa Diagnostic’s drive for IDE approval of its rapid-response breath test for pneumonia, TB, CF, and other lung ailments. read more >

STAAR Shares Burst Higher after Firm Posts 77% Increase in Q2 Net Sales and Raises FY Outlook

  ()
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses. read more >

Coverage Initiated on Company with a 'Genuine Physiological Heart Replacement Therapy'

Research Report
  ()
The investment thesis for the device company Carmat, whose therapy "allows patients to live with almost normal quality of life," is presented in an H.C. Wainwright & Co. report. read more >

Biopharma Partners with NIH to Advance Women's Hormone-Free Contraceptive

Research Report
  ()
A Roth Capital Partners report calls this a "very cost-effective and strategic move" for Daré Bioscience. read more >

Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook

  ()
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. read more >

Pulse Bio Shares Beat Higher on Launch of CellFX NPS System in Canada

  ()
Pulse Biosciences shares traded 27% higher after the company announced it secured a $50 million private placement one day after it reported the first CellFX® procedure using its proprietary Nano-Pulse Stimulation technology had been performed in Canada. read more >

Second Sight Shares Shine Brightly After Firm Posts Orion Study Results

  ()
Second Sight Medical Products Inc. shares traded 25% higher after the company reported the results from a two-year study of its Orion Visual Cortical Prosthesis System. read more >

AbbVie's Allergan Aesthetics to Acquire Soliton for $550 Million

  ()
Soliton Inc. shares traded 25% higher after the company reported it had agreed to be acquired by AbbVie Inc.'s Allergan Aesthetics for $22.60 per share in an all cash transaction. read more >

CryoLife Shares Trade 18% Higher on Q1 Financial Results

  ()
Shares of CryoLife Inc. set a new 52-week high intraday price after the company reported that total revenues in Q1/21 increased by 7% YoY to $71.1 million. read more >

Nano-X Imaging Receives Go Ahead from FDA for Single Source Digital X-Ray

  ()
Shares of Nano-X Imaging Ltd. traded 17% higher after the company reported that the FDA has granted 510(k) approval for its single source ARC digital x-ray. read more >

Shockwave Medical Reports 100% Increase in Preliminary Q1 Revenue

  ()
Shockwave Medical Inc. shares gained 19% after the company announced that sales of its recently launched C2 Coronary IVL System are growing steadily and are driving revenue growth. read more >
Showing Results: 1 to 14 of 14

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe